{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:13:43Z","timestamp":1788488023422,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Public Health Clinical Center","award":["KY-GW-2024-03"],"award-info":[{"award-number":["KY-GW-2024-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13850-1","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:34:57Z","timestamp":1782178497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HPV genotype distribution and risk factors for cervical dysplasia among HPV-positive women with or without HIV infection in Shanghai, China"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuxi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"3","key":"13850_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"13850_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ijc.35369","volume":"157","author":"Z Li","year":"2025","unstructured":"Li Z, Liu P, Yin A, Zhang B, Xu J, Chen Z, Zhang Z, Zhang Y, Wang S, Tang L, et al. Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer. Int J Cancer. 2025;157(2):288\u201397.","journal-title":"Int J Cancer"},{"issue":"1","key":"13850_CR3","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","journal-title":"J Natl Cancer Cent"},{"key":"13850_CR4","doi-asserted-by":"crossref","unstructured":"Boldeanu L, Assani MZ, Boldeanu MV, Silo\u0219i I, Manolea MM, V\u0103duva CC, Assani AD, Dijm\u0103rescu AL. Cervical cancer in the era of HPV: translating molecular mechanisms into preventive public health action. Int J Mol Sci. 2025;26(17).","DOI":"10.3390\/ijms26178463"},{"key":"13850_CR5","doi-asserted-by":"publisher","first-page":"e2021039","DOI":"10.4178\/epih.e2021039","volume":"43","author":"JO Okoye","year":"2021","unstructured":"Okoye JO, Ofodile CA, Adeleke OK, Obioma O. Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review. Epidemiol Health. 2021;43:e2021039.","journal-title":"Epidemiol Health"},{"issue":"14","key":"13850_CR6","doi-asserted-by":"publisher","first-page":"e9545","DOI":"10.1097\/MD.0000000000009545","volume":"97","author":"RM Badial","year":"2018","unstructured":"Badial RM, Dias MC, Stuqui B, Melli P, Quintana SM, Bonfim CMD, Cordeiro JA, Rabachini T, Calmon MF, Provazzi PJS, et al. Detection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV\/HIV co-infection. Med (Baltim). 2018;97(14):e9545.","journal-title":"Med (Baltim)"},{"key":"13850_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/1743-422X-8-269","volume":"8","author":"R Faridi","year":"2011","unstructured":"Faridi R, Zahra A, Khan K, Idrees M. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J. 2011;8:269.","journal-title":"Virol J"},{"issue":"10167","key":"13850_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169\u201382.","journal-title":"Lancet"},{"key":"13850_CR9","doi-asserted-by":"publisher","first-page":"695254","DOI":"10.3389\/frph.2021.695254","volume":"3","author":"M Lall","year":"2021","unstructured":"Lall M, Dar L, Bhatla N, Kumar P, Choudhary A, Mathur SR, Gupta RM. Prevalence of Human Papillomavirus (HPV) Genotypes in Cervicovaginal Secretions of Human Immunodeficiency Virus (HIV) Positive Indian Women and Correlation With Clinico-Virological Parameters. Front Reprod Health. 2021;3:695254.","journal-title":"Front Reprod Health"},{"issue":"2","key":"13850_CR10","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","volume":"9","author":"D Stelzle","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, McAllister DA, Gottlieb SL, Klug SJ, Winkler AS, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161\u20139.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"13850_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13643-020-01354-1","volume":"9","author":"KMB Lekoane","year":"2020","unstructured":"Lekoane KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG. The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review. Syst Rev. 2020;9(1):88.","journal-title":"Syst Rev"},{"issue":"5","key":"13850_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/CCO.0b013e3283094ed8","volume":"20","author":"EA Stier","year":"2008","unstructured":"Stier EA, Baranoski AS. Human papillomavirus-related diseases in HIV-infected individuals. Curr Opin Oncol. 2008;20(5):541\u20136.","journal-title":"Curr Opin Oncol"},{"issue":"7","key":"13850_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1590\/0074-02760160530","volume":"112","author":"GR de Oliveira","year":"2017","unstructured":"de Oliveira GR, Vieira VC, \u00c1vila EC, Finger-Jardim F, Caldeira TD, Gatti FA, Gon\u00e7alves CV, Oliveira SG, da Hora VP, Soares MA, et al. Human papillomavirus type distribution and HPV16 intratype diversity in southern Brazil in women with and without cervical lesions. Mem Inst Oswaldo Cruz. 2017;112(7):492\u20138.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"13850_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12885-025-13516-2","volume":"25","author":"TD Swase","year":"2025","unstructured":"Swase TD, Fasogbon IV, Eseoghene IJ, Etukudo EM, Mbina SA, Joan C, Dangana RS, Anyanwu C, Vandu CD, Agbaje AB, et al. The impact of HPV\/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers. BMC Cancer. 2025;25(1):202.","journal-title":"BMC Cancer"},{"issue":"1","key":"13850_CR15","doi-asserted-by":"publisher","first-page":"10114","DOI":"10.1038\/s41467-024-53830-0","volume":"15","author":"J Yu","year":"2024","unstructured":"Yu J, Gui X, Zou Y, Liu Q, Yang Z, An J, Guo X, Wang K, Guo J, Huang M, et al. A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights. Nat Commun. 2024;15(1):10114.","journal-title":"Nat Commun"},{"issue":"4","key":"13850_CR16","doi-asserted-by":"publisher","first-page":"e24851","DOI":"10.1002\/jcla.24851","volume":"37","author":"H Aziz","year":"2023","unstructured":"Aziz H, Sattar AA, Mahmood H, Fatima S, Khurshid M, Faheem M. Prevalence of HPV types in HIV-positive and negative females with normal cervical cytology or dysplasia. J Clin Lab Anal. 2023;37(4):e24851.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"13850_CR17","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12885-022-09966-7","volume":"22","author":"L Glasmeyer","year":"2022","unstructured":"Glasmeyer L, McHaro RD, Torres L, Lennemann T, Danstan E, Mwinuka N, Judick M, Mueller W, Mbuya W, H\u00f6lscher M, et al. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting. BMC Cancer. 2022;22(1):892.","journal-title":"BMC Cancer"},{"issue":"9","key":"13850_CR18","doi-asserted-by":"publisher","first-page":"e0257324","DOI":"10.1371\/journal.pone.0257324","volume":"16","author":"O Kuguyo","year":"2021","unstructured":"Kuguyo O, Dube Mandishora RS, Thomford NE, Makunike-Mutasa R, Nhachi CFB, Matimba A, Dandara C. High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women. PLoS ONE. 2021;16(9):e0257324.","journal-title":"PLoS ONE"},{"issue":"1","key":"13850_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12985-024-02405-y","volume":"21","author":"D Bi","year":"2024","unstructured":"Bi D, Wei S, Luo X, Luo X, Tang X. Management for persistent HPV infection and cervical lesions among women infected with HIV: a retrospective observational cohort study. Virol J. 2024;21(1):133.","journal-title":"Virol J"},{"issue":"4","key":"13850_CR20","first-page":"247","volume":"98","author":"R Duan","year":"2022","unstructured":"Duan R, Zhang H, Wu A, Li C, Li L, Xu X, Qiao Y, Zhao F, Clifford G. Prevalence and risk factors for anogenital HPV infection and neoplasia among women living with HIV in China. Sex Transm Infect. 2022;98(4):247\u201354.","journal-title":"Sex Transm Infect"},{"issue":"3","key":"13850_CR21","first-page":"206","volume":"33","author":"YP Qiao","year":"2020","unstructured":"Qiao YP, Wang AL, Fang LW, Hann K, Wang LH. High-risk Human Papillomavirus Infection and Associated Factors among HIV-positive Women in High HIV-burden Areas of China. Biomed Environ Sci. 2020;33(3):206\u201312.","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"13850_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/QAI.0000000000002941","volume":"90","author":"C Nakisige","year":"2022","unstructured":"Nakisige C, Adams SV, Namirembe C, Okoche L, Ferrenberg J, Towlerton A, Larsen A, Orem J, Casper C, Frenkel L, et al. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2022;90(3):333\u201342.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"13850_CR23","doi-asserted-by":"crossref","unstructured":"Gouton CD, Bejide IO, Ope-Ewe OO, Adjagba M, Azonbakin S, Muzanywa G, Akinyi FT, Agbanlinsou A, Goussanou Y, Folarin O, et al. HIV-HPV co-infection and identification of novel high-risk HPV among women at two hospital centers in Cotonou, Republic of Benin. Viruses. 2025;17(5).","DOI":"10.3390\/v17050714"},{"key":"13850_CR24","doi-asserted-by":"crossref","unstructured":"Taku O, Mbulawa ZZA, Phohlo K, Garcia-Jardon M, Businge CB, Williamson AL. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-negative and HIV-positive women with cervical intraepithelial lesions in the Eastern Cape Province, South Africa. Viruses. 2021;13(2).","DOI":"10.3390\/v13020280"},{"key":"13850_CR25","doi-asserted-by":"crossref","unstructured":"Njue JK, Muturi M, Kamau L, Lwembe R. Human papillomavirus types associated with cervical dysplasia among HIV- and Non-HIV-infected women attending reproductive health clinics in Eastern Kenya. Biomed Res Int. 2021;2021:2250690.","DOI":"10.1155\/2021\/2250690"},{"issue":"2","key":"13850_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41579-021-00617-5","volume":"20","author":"AA McBride","year":"2022","unstructured":"McBride AA. Human papillomaviruses: diversity, infection and host interactions. Nat Rev Microbiol. 2022;20(2):95\u2013108.","journal-title":"Nat Rev Microbiol"},{"key":"13850_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijid.2021.07.059","volume":"110","author":"R Tagne Simo","year":"2021","unstructured":"Tagne Simo R, Kiafon FB, Nangue C, Goura AP, Ebune JL, Usani MC, Nwabo Kamdje AH, Seke Etet PF, Telefo PB. Influence of HIV infection on the distribution of high-risk HPV types among women with cervical precancerous lesions in Yaounde, Cameroon. Int J Infect Dis. 2021;110:426\u201332.","journal-title":"Int J Infect Dis"},{"issue":"50","key":"13850_CR28","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1016\/j.vaccine.2022.10.029","volume":"40","author":"C Gilles","year":"2022","unstructured":"Gilles C, Rozenberg S, Buxant F, Manigart Y, de Wind R, Houte KV, Vandenbroeck D, Delforge M, Konopnicki D. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study. Vaccine. 2022;40(50):7230\u20137.","journal-title":"Vaccine"},{"issue":"1","key":"13850_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12985-023-02125-9","volume":"20","author":"ZY Yan","year":"2023","unstructured":"Yan ZY, Di XH, Qiu Y, Ying YY, Gan J, Xu HH. Cervical carcinogenesis risk association of HPV33 E6 and E7 genetic variations in Taizhou, Southeast China. Virol J. 2023;20(1):156.","journal-title":"Virol J"},{"issue":"1","key":"13850_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12916-025-03975-6","volume":"23","author":"S Han","year":"2025","unstructured":"Han S, Lin M, Liu M, Wu S, Guo P, Guo J, Xie L, Qiu S, Xu A, Cai Y, et al. Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases. BMC Med. 2025;23(1):158.","journal-title":"BMC Med"},{"issue":"11","key":"13850_CR31","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/tmi.13142","volume":"23","author":"M Camargo","year":"2018","unstructured":"Camargo M, Del R\u00edo-Ospina L, Soto-De Le\u00f3n SC, S\u00e1nchez R, Pineda-Pe\u00f1a AC, Sussmann O, Patarroyo ME, Patarroyo MA. Association of HIV status with infection by multiple HPV types. Trop Med Int Health. 2018;23(11):1259\u201368.","journal-title":"Trop Med Int Health"},{"issue":"6","key":"13850_CR32","first-page":"505","volume":"71","author":"PE Castle","year":"2021","unstructured":"Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus. CA Cancer J Clin. 2021;71(6):505\u201326.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"13850_CR33","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1128\/JCM.00087-13","volume":"51","author":"M Schmitt","year":"2013","unstructured":"Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol. 2013;51(5):1458\u201364.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"13850_CR34","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1158\/1055-9965.EPI-06-0129","volume":"15","author":"H Trottier","year":"2006","unstructured":"Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1274\u201380.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"13850_CR35","doi-asserted-by":"crossref","unstructured":"Mbulawa ZZA, Kondlo S, Toni S, Faye LM, Businge CB. Prevalence, Characteristics, and distribution of human papillomavirus according to age and HIV status in women of Eastern Cape Province, South Africa. Viruses. 2024;16(11).","DOI":"10.3390\/v16111751"},{"key":"13850_CR36","unstructured":"WHO. Human Papillomavirus Vaccines: WHO Position Paper. World Health Organization; 2022."},{"key":"13850_CR37","doi-asserted-by":"publisher","first-page":"101585","DOI":"10.1016\/j.eclinm.2022.101585","volume":"52","author":"L Staadegaard","year":"2022","unstructured":"Staadegaard L, R\u00f6nn MM, Soni N, Bellerose ME, Bloem P, Brisson M, Maheu-Giroux M, Barnabas RV, Drolet M, Mayaud P, et al. Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis. EClinicalMedicine. 2022;52:101585.","journal-title":"EClinicalMedicine"},{"key":"13850_CR38","doi-asserted-by":"publisher","first-page":"101306","DOI":"10.1016\/j.eclinm.2022.101306","volume":"45","author":"G Liu","year":"2022","unstructured":"Liu G, Mugo NR, Bayer C, Rao DW, Onono M, Mgodi NM, Chirenje ZM, Njoroge BW, Tan N, Bukusi EA, et al. Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence. EClinicalMedicine. 2022;45:101306.","journal-title":"EClinicalMedicine"},{"issue":"32 Pt A","key":"13850_CR39","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1016\/j.vaccine.2018.02.023","volume":"36","author":"N Tan","year":"2018","unstructured":"Tan N, Sharma M, Winer R, Galloway D, Rees H, Barnabas RV. Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa. Vaccine. 2018;36(32 Pt A):4830\u20136.","journal-title":"Vaccine"},{"issue":"6","key":"13850_CR40","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. Aids. 2018;32(6):795\u2013808.","journal-title":"Aids"},{"issue":"3","key":"13850_CR41","first-page":"403","volume":"96","author":"I Heard","year":"2000","unstructured":"Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet Gynecol. 2000;96(3):403\u20139.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"13850_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jana.2012.06.010","volume":"24","author":"CL Chapman Lambert","year":"2013","unstructured":"Chapman Lambert CL. Factors influencing cervical cancer screening in women infected with HIV: a review of the literature. J Assoc Nurses AIDS Care. 2013;24(3):189\u201397.","journal-title":"J Assoc Nurses AIDS Care"},{"key":"13850_CR43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ijid.2020.10.083","volume":"103","author":"MJ Brito","year":"2021","unstructured":"Brito MJ, Sequeira P, Silva I, Quintas A, Martins C, F\u00e9lix A. CD4(+) and CD8(+) cell populations in HIV-positive women with cervical squamous intra-epithelial lesions and squamous cell carcinoma. Int J Infect Dis. 2021;103:370\u20137.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"13850_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/QAI.0000000000002420","volume":"85","author":"S Grover","year":"2020","unstructured":"Grover S, Mehta P, Wang Q, Bhatia R, Bvochora-Nsingo M, Davey S, Iyengar M, Shah S, Shin SS, Zetola NM. Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV. J Acquir Immune Defic Syndr. 2020;85(2):201\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1 Suppl","key":"13850_CR45","first-page":"e746","volume":"128","author":"NN Nkwanyana","year":"2009","unstructured":"Nkwanyana NN, Gumbi PP, Roberts L, Denny L, Hanekom W, Soares A, Allan B, Williamson AL, Coetzee D, Olivier AJ, et al. Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract. Immunology. 2009;128(1 Suppl):e746\u2013757.","journal-title":"Immunology"},{"issue":"21","key":"13850_CR46","doi-asserted-by":"publisher","first-page":"11708","DOI":"10.1128\/JVI.77.21.11708-11717.2003","volume":"77","author":"M Guadalupe","year":"2003","unstructured":"Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S. Severe CD4\u2009+\u2009T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol. 2003;77(21):11708\u201317.","journal-title":"J Virol"},{"issue":"1","key":"13850_CR47","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","volume":"5","author":"H Kelly","year":"2018","unstructured":"Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018;5(1):e45\u201358.","journal-title":"Lancet HIV"},{"issue":"10","key":"13850_CR48","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1093\/cid\/ciaa238","volume":"71","author":"N Atemnkeng","year":"2020","unstructured":"Atemnkeng N, Aji AD, de Sanjose S, Mayaud P, Kelly H. Antiretroviral Therapy and Detection of High-grade Cervical Intraepithelial Neoplasia (CIN2+) at Post-CIN Management Follow-up Among Women Living With Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2020;71(10):e540\u20138.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13850-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13850-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13850-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:45:24Z","timestamp":1788486324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13850-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13850"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13850-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Shanghai Public Health Clinical Center (Ethical approval number: KY-GW-2024-03) and complied with the principles of the 2013 revision of the Helsinki Declaration.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1603"}}